FDA data Registry peer set 3 peers

Alternatives to tiotropium

3 same-class SPL records vs tiotropium - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Spiriva

Long-Acting Muscarinic Antagonist (LAMA) Prescription 3 alternatives found

About tiotropium

STIOLTO RESPIMAT is a medicine that combines two drugs to help people with COPD breathe easier. It is used daily to keep airways open.

Used for: STIOLTO RESPIMAT is used to treat chronic obstructive pulmonary disease (COPD). COPD includes chronic bronchitis and emphysema. This medicine helps you breathe better over a long period. It is not for sudden breathing problems.

3 Long-Acting Muscarinic Antagonist (LAMA) peers (wide set)

Compare tiotropium vs aclidinium side-by-side →

tiotropium vs aclidinium & glycopyrrolate · FAERS reaction fields

FAERS top-reaction field "Using the medicine the wrong way" shows the widest count spread between tiotropium and aclidinium, glycopyrrolate, umeclidinium in this extract (23,320-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect tiotropium aclidiniumglycopyrrolateumeclidinium
Using the medicine the wrong way 23,320 - - -
Difficulty breathing 22,319 1,869 - -
Asthma 10,817 814 793 604
Cough 8,611 655 626 701
Pneumonia 8,380 692 538 509
Wheezing 6,761 645 674 325
Chronic obstructive pulmonary disease 6,235 - - -
Problem with the medicine's quality 5,971 - - -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

tiotropium peer mix vs class inventory

Peer mix

0 OTC and 3 Rx SPL records in this peer set (3 total). Class inventory for Long-Acting Muscarinic Antagonist (LAMA): 4 drugs.

Frequently Asked Questions

What same-class SPL records sit beside tiotropium?
This registry lists 3 Long-Acting Muscarinic Antagonist (LAMA) medication records beside tiotropium, including aclidinium, glycopyrrolate, umeclidinium. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Long-Acting Muscarinic Antagonist (LAMA) peer set (3 records)

tiotropium (Spiriva) sits in a wide Long-Acting Muscarinic Antagonist (LAMA) peer set (3 of 3 class peers shown). Labeled indication field for tiotropium: STIOLTO RESPIMAT is used to treat chronic obstructive pulmonary disease (COPD).

Top FAERS reaction fields for tiotropium total 102,307 reports across 10 reactions, set beside aclidinium, glycopyrrolate, umeclidinium. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full tiotropium profile →

Field note for tiotropium: see also the generic vs brand label guide when reading Spiriva SPL strings.